Pharma Journalist -

BioCryst Pharmaceuticals, Inc. announced the first patients have been dosed with BCX9930 in a proof of concept trial in paroxysmal nocturnal hemoglobinuria (PNH). These patients were…
Read More...

Urovant Sciences announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the…
Read More...

AMAG Pharmaceuticals, Inc. announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer,…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Elecsys GALAD score. This algorithmic score combines gender and age…
Read More...

Takeda Pharmaceutical Company Limited will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin…
Read More...

Vir Biotechnology, Inc.and Alnylam Pharmaceuticals, Inc. announced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics…
Read More...

Amunix Pharmaceuticals, Inc. announced the successful completion of an oversubscribed $73 million Series A financing. Boston-based Omega Funds led the financing, with participation from…
Read More...

Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) announced their partnership to develop a Coronavirus (COVID-19) vaccine for Singapore. The development of a COVID-19 vaccine…
Read More...

Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international…
Read More...

MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions…
Read More...